Dopesick: An Interview with Beth Macy

It takes the average user eight years and five to six treatment attempts just to achieve one year of sobriety. And in an era of fentanyl and other even stronger synthetic opioids, many users don’t have eight years. As recently as a few years ago, the opioid crisis could be referred to as a “silent… Continue reading Dopesick: An Interview with Beth Macy

Demi Lovato’s Alleged Dealer Claims She Knew Pills Were Risky

Friends of Lovato’s said they became concerned when they learned that the singer had begun spending time with Brandon Johnson in April. The man who allegedly provided singer Demi Lovato with the pills that she overdosed on in July said that he warned the singer that the pills were “aftermarket” and that she knew the… Continue reading Demi Lovato’s Alleged Dealer Claims She Knew Pills Were Risky

New York Sues Purdue Pharma Over Opioid Marketing

New York plans to work with other states that are investigating opioid manufacturers and distributors in the US. This week, New York became the 27th state to sue Purdue Pharma, a producer of OxyContin, for alleged fraud and deception in its marketing of opioids. The Wall Street Journal reported that Purdue is the only defendant… Continue reading New York Sues Purdue Pharma Over Opioid Marketing

New Book "Dopesick" Explores The Opioid Crisis From All Angles

“My goal with this book was not to just show you how we got here and what it’s going to take to get out of it but also to inspire people to care,” says author Beth Macy. Journalist Beth Macy set out with a mission: to address the opioid epidemic from every possible angle.  In… Continue reading New Book "Dopesick" Explores The Opioid Crisis From All Angles

Purdue Pharma Reportedly Worried About Losing Money To Rivals Amid Oxy Panic

A new report details the early rivalry among opioid drug makers who sought to follow in the profitable footsteps of Purdue Pharma. As Purdue Pharma came under fire from federal investigators for unscrupulous advertising practices, the company was reportedly concerned about losing market share to other drug manufacturers, according to internal documents.  “Market research as… Continue reading Purdue Pharma Reportedly Worried About Losing Money To Rivals Amid Oxy Panic

Purdue Pharma Knew About Oxy Misuse Early On, Report Finds

The report also alleges that in 1999 company officials learned of a call to a pharmacy describing “OxyContin as the hottest thing on the street—forget Vicodin.” Purdue Pharma reportedly knew that the opioid pill OxyContin was being snorted and sold on the street as early as 1999, just three years after the medication’s release. However,… Continue reading Purdue Pharma Knew About Oxy Misuse Early On, Report Finds

Massive Drug Spoon Sculpture Dropped At Purdue Pharma HQ

The message behind the guerrilla art exhibit is to call attention to the potential danger of prescription opioids. A gallery owner was arrested Friday morning (June 22) after placing a sculpture of a massive steel spoon at the headquarters of Purdue Pharma, the maker of OxyContin. Fernando Louis Alvarez was arrested and charged with obstruction… Continue reading Massive Drug Spoon Sculpture Dropped At Purdue Pharma HQ

Accused Dark Web Kingpin "OxyMonster" Faces 20-Year Sentence

Federal agents captured the accused drug kingpin when he came to the US for a beard contest last summer. The man who is accused of selling oxycodone, cocaine and methamphetamine online under the alias “OxyMonster” will reportedly plead guilty in federal court on charges of drug conspiracy and money laundering, the Associated Press reported on… Continue reading Accused Dark Web Kingpin "OxyMonster" Faces 20-Year Sentence

Exit mobile version